|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
|
Fig. 3. (A) RPTPmo embryos show defects in somitogenesis and a shortening
of the body axis. (B) The effect of increasing RPTPmo dose on
myod expression at 26 hpf. Uninjected control, 4 ng, 6 ng and 8 ng
RPTPmo/embryo.
|